Today, the ACCESS-AD consortium is announcing the launch of a transformative European initiative that will accelerate the ...

ACCESS-AD launches at a pivotal time for Alzheimer’s disease management in Europe. Recent approvals of antibody-based disease-modifying therapies (DMTs) have expanded the treatment landscape, but ...

RetinalGenix Technologies Inc. [OTCQB: RTGN] ('RetinalGenix” or the 'Company”), a company developing ultra-high-resolution ...

Researchers have discovered a brain activity pattern that can predict which people with mild cognitive impairment are likely ...

Regular aerobic exercise may help slow biological brain aging in adults. In a randomized clinical trial, researchers used MRI ...

According to the paper, artificial intelligence addresses a core weakness in Parkinson’s care: reliance on subjective ...

A 62-year-old woman with stage IIIA lung cancer faces complex diagnostic and treatment decisions, highlighting the importance ...

Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...

Qureight, a techbio company advancing the understanding of lung and heart disease, has appointed Dr. Steven Bishop as Chief Medical Officer (CMO).

Lotus Endometriosis Institute releases important update on microRNA research for potential non-invasive blood test to ...

Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled prion disease; a 2025 study offered explanations, but some patients rejected ...